Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Potent, orally active ACAT inhibitors from Sankyo

April 24, 1997

Azko Nobel discloses antiglucocorticoids

April 24, 1997

Antioxidants/hypolipidemics from ADIR

April 24, 1997

Ono discloses ICE inhibitors

April 23, 1997

New agents for postmenopausal syndrome described by Lilly

April 23, 1997

Gensia Sicor and Sankyo collaborate in diabetes research

April 22, 1997

New selective estrogen receptor modulator from Lilly

April 22, 1997

Pfizer discovers potent, selective beta3-adrenoceptor full agonist

April 22, 1997

Astra Arcus develops selective CCK-A agonist with potential for obesity

April 22, 1997

First launch for Lipobay

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...